INPP5D and B-cell chronic lymphocytic leukemia: Importantly, blocking ROS levels derived from oxidative phosphorylation with a mitochondria-targeted antioxidant (mitoTEMPO) significantly reduced the cytotoxicity of SHIP1 inhibition in MEC-1 cells (Fig. 5g) and primary CLL cells (Fig. 5h).